Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Kenya becomes third African nation to introduce malaria vaccine

Fri, 13th Sep 2019 13:56

(Adds details of vaccine, statement from WHO Africa director)

NAIROBI, Sept 13 (Reuters) - Kenya on Friday began adding a
malaria vaccine to its routine immunization schedule for babies
and toddlers, becoming the third African country to roll out the
vaccine for a disease that threatens children across the
continent.

Malaria, which kills one child globally every two minutes,
is the top killer of children under five in the east African
country. The vaccine - the world's first against malaria - will
be administered to children under two and could be crucial to
efforts to combat the disease, health officials said.

Other measures, such as nets to protect people from the
mosquitoes that carry the malaria parasite, have not proven
adequate to halt transmission, the director general of Kenya's
health ministry, Wekesa Masasabi, told Reuters.

"We still have an incidence of 27% (malaria infection) for
children under five," Masasabi said before Friday's launch of
the vaccine in the western county of Homa Bay.

The Homa Bay programme is the government's first step toward
creating awareness of the new vaccine, he said.

The injectable vaccine, called RTS,S or Mosquirix, was
developed by British drugmaker GlaxoSmithKline to
protect children from the most deadly form of malaria in Africa.

In clinical trials it proved only partially effective and it
needs to be given in a four-dose schedule, but it is the first
regulator-approved vaccine against the disease.

It has already been deployed in pilot programmes in Ghana
and Malawi.

Malaria infected about 219 million people in 2017 and killed
around 435,000. The vast majority of malaria deaths are among
babies and children in the poorest parts of Africa. Due to
ongoing transmission, half the world's population is still at
risk of contracting the disease.

The World Health Organization's regional director for
Africa, Matshidiso Moeti, said the Kenyan, Ghanaian and Malawian
pilots would provide key information and data for a future WHO
policy on broader use of the vaccine in sub-Saharan Africa.

A recent surge in malaria cases and deaths in the region is
threatening gains in the fight against the disease, she said,
adding that the vaccine "has the potential to save tens of
thousands of lives."

Kenya plans to roll out RTS,S to eight of its 47 counties
over the next two years, Masasabi said.

In a major report published last weekend, global health
experts said malaria could be eradicated within a generation
with the right tools, funding and political will.

Commissioned by The Lancet medical journal, the report
contradicted the conclusions last month of a malaria review by
the WHO. The experts urged the U.N. agency not to shy away from
this "goal of epic proportions".
(Reporting by Maggie Fick in Niarobi and Kate Kelland in London
Editing by Tom Hogue and Frances Kerry)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.